World-first clinical trial with 'man's best friend' could unlock treatment breakthrough for kids with cancer

by Telethon Kids InstituteThree-year-old Bull Terrier, Maggie, is about to undergo surgery using the immunotherapy gel to treat her sarcoma. It is hoped the world-first clinical trial in dogs will be

Updated on: January 04,2024 9

World-first clinical trial with 'man's best friend' could unlock treatment breakthrough for kids with cancer

by Telethon Kids InstituteThree-year-old Bull Terrier, Maggie, is about to undergo surgery using the immunotherapy gel to treat her sarcoma. It is hoped the world-first clinical trial in dogs will be

Updated on:January 04,2024 9

Why new cancer treatment discoveries are proliferating

by Karen L. Brooks,University of PennsylvaniaSunil Singhal, MD, examines lung tissue during a surgical procedure using a glowing tumor agent, while a colleague observes. Credit: University of Pe

Updated on: January 08,2024 10

Why new cancer treatment discoveries are proliferating

by Karen L. Brooks,University of PennsylvaniaSunil Singhal, MD, examines lung tissue during a surgical procedure using a glowing tumor agent, while a colleague observes. Credit: University of Pe

Updated on:January 08,2024 10

A blood sample 24 hours after the start of chemotherapy can predict survival

byUniversity of BergenMass cytometry analysis of early response evaluation by single-cell signaling to profile.aPeripheral blood samples were collected from 32 AML patients treated w

Updated on: December 25,2023 12

A blood sample 24 hours after the start of chemotherapy can predict survival

byUniversity of BergenMass cytometry analysis of early response evaluation by single-cell signaling to profile.aPeripheral blood samples were collected from 32 AML patients treated w

Updated on:December 25,2023 12

Protein spheres protect the genome of cancer cells

byUniversity of WürzburgMYC proteins are colored green in this figure. In normally growing cells, they are homogeneously distributed in the cell nucleus (left). In diverse stress situations, as

Updated on: December 20,2023 10

Protein spheres protect the genome of cancer cells

byUniversity of WürzburgMYC proteins are colored green in this figure. In normally growing cells, they are homogeneously distributed in the cell nucleus (left). In diverse stress situations, as

Updated on:December 20,2023 10

New model explains how our immune system sometimes helps cancer spread

by Katie Willis,University of AlbertaCredit: CC0 Public DomainMathematicians at the University of Alberta have developed a model that explains how the immune system interacts with cancer—and in

Updated on: December 22,2023 12

New model explains how our immune system sometimes helps cancer spread

by Katie Willis,University of AlbertaCredit: CC0 Public DomainMathematicians at the University of Alberta have developed a model that explains how the immune system interacts with cancer—and in

Updated on:December 22,2023 12

New study seeks hereditary causes of childhood cancer

byKarolinska InstitutetOverview of study design and study cohort. Credit:The Lancet Regional Health—Europe(2024). DOI: 10.1016/j.lanepe.2024.100881Follow-up and treatment of children

Updated on: April 28,2024 0

New study seeks hereditary causes of childhood cancer

byKarolinska InstitutetOverview of study design and study cohort. Credit:The Lancet Regional Health—Europe(2024). DOI: 10.1016/j.lanepe.2024.100881Follow-up and treatment of children

Updated on:April 28,2024 0

New Kaiser genomics lab uses robots for faster, cheaper routine genetic tests

by Harriet Blair Rowan, The Mercury NewsCredit: CC0 Public DomainAn archway of blue and white balloons adorned the entrance of an otherwise unremarkable office building in San Jose this week, marking

Updated on: April 06,2024 0

New Kaiser genomics lab uses robots for faster, cheaper routine genetic tests

by Harriet Blair Rowan, The Mercury NewsCredit: CC0 Public DomainAn archway of blue and white balloons adorned the entrance of an otherwise unremarkable office building in San Jose this week, marking

Updated on:April 06,2024 0

Inhibition of prmt5 by repurposing market drugs: A fresh therapeutic pathway for cancer treatment

by TranSpreadDevelopment of AlphaLISA HTS screen to identify specific PRMT5 inhibitors. (A) Principle of AlphaLISA technique adapted to HTS. Biotinylated histone H4 (a well-known PRMT5 substrate) was

Updated on: January 04,2024 9

Inhibition of prmt5 by repurposing market drugs: A fresh therapeutic pathway for cancer treatment

by TranSpreadDevelopment of AlphaLISA HTS screen to identify specific PRMT5 inhibitors. (A) Principle of AlphaLISA technique adapted to HTS. Biotinylated histone H4 (a well-known PRMT5 substrate) was

Updated on:January 04,2024 9

Men with low-/intermediate-risk prostate cancer benefit from fewer, higher-dose radiation treatments

byAmerican Society for Radiation OncologyStereotactic body radiation therapy (SBRT) is a safe and effective treatment for men with low- and intermediate-risk prostate cancer, according to a long

Updated on: December 18,2023 23

Men with low-/intermediate-risk prostate cancer benefit from fewer, higher-dose radiation treatments

byAmerican Society for Radiation OncologyStereotactic body radiation therapy (SBRT) is a safe and effective treatment for men with low- and intermediate-risk prostate cancer, according to a long

Updated on:December 18,2023 23

FDA Approves Lymphir: A New Hope for CTCL Patients

The U.S. Food and Drug Administration (FDA) had approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.

Updated on: August 12,2024 0

FDA Approves Lymphir: A New Hope for CTCL Patients

The U.S. Food and Drug Administration (FDA) had approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.

Updated on:August 12,2024 0

Preventing 'identity theft' in prostate cancer cells re-sensitizes them to therapy

byUT Southwestern Medical CenterJAK–STAT signaling is required for Enz resistance in TP53/RB1-deficient mCRPC.a, Heat map representing the significantly changed signaling pathways in LNCaP

Updated on: December 22,2023 15

Preventing 'identity theft' in prostate cancer cells re-sensitizes them to therapy

byUT Southwestern Medical CenterJAK–STAT signaling is required for Enz resistance in TP53/RB1-deficient mCRPC.a, Heat map representing the significantly changed signaling pathways in LNCaP

Updated on:December 22,2023 15

Colonoscopy is the most comprehensive screening for colorectal cancer, despite flawed interpretations of a new study

by Franklin G. Berger,The ConversationCredit: American College of GastroenterologyA recently published study in a high-profile medical journal appeared to call into questionthe efficacy of

Updated on: December 26,2023 13

Colonoscopy is the most comprehensive screening for colorectal cancer, despite flawed interpretations of a new study

by Franklin G. Berger,The ConversationCredit: American College of GastroenterologyA recently published study in a high-profile medical journal appeared to call into questionthe efficacy of

Updated on:December 26,2023 13